Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Protein-Sparing Modified Fast

The Muscle-Preserving Medical Fast

Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.

6 human trials, about 200 studies, Clinical cohorts since the 1970s. The written rationale for this grade is still being prepared.

FDA
Used clinically; related VLCDs have medical-device/food status
WADA
Not prohibited

Reference only. Not medical advice.

What can go wrong

PSMF is demanding and is associated with real risks when formulation and monitoring are inadequate: electrolyte imbalance (notably potassium and magnesium), gallstones and gallbladder sludging from rapid loss, transient liver-enzyme elevation, and, historically, dangerous ventricular arrhythmias with low-biological-value protein and inadequate mineral support. The late-1970s liquid-protein-diet deaths, roughly 58 to 60 reported to the FDA and CDC and mostly in women, are the defining cautionary precedent and showed QT prolongation and ventricular tachycardia. PSMF is not appropriate without qualified medical supervision, especially for extended periods, in adolescents, in pregnancy, or alongside an eating disorder history. Anyone considering rapid weight loss should work with a qualified physician or registered dietitian who can screen, supervise, and monitor labs rather than attempting it alone.

The protein-sparing modified fast (PSMF) is a medically developed very-low-calorie protocol that supplies adequate high-quality protein to protect lean mass while cutting carbohydrate and fat to near zero, driving rapid fat loss and ketosis. It was developed in 1970s clinical obesity medicine by George Blackburn and Bruce Bistrian at Harvard as a deliberate, supervised improvement on total fasting and on the crude commercial liquid-protein drinks of the same era. Its efficacy for short-term weight reduction is associated with supervised use in cohorts such as the 668-patient Palgi 1985 series and small later trials. Its defining safety lesson is the late-1970s liquid-protein-diet episode, in which roughly 58 to 60 deaths, mostly in women, were reported to the FDA and CDC among users of poorly formulated products. That history is why electrolyte support, protein quality, and qualified medical supervision are treated as non-negotiable.

A medically designed fast that keeps protein high to protect muscle while driving rapid fat loss, effective but requiring supervision.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Rapid medically supervised fat loss in obesity
  • Muscle preservation during a steep caloric deficit
  • Pre-surgical or metabolic clinical contexts where rapid reduction lowers operative risk
  • A more lean-mass-sparing approach than total water fasting

What people get wrong

  • Often saidFasting and PSMF lose the same kind of weight

    ActuallyPSMF is specifically designed to preserve lean mass by keeping high-quality protein high, whereas pure starvation and very-low-protein liquid diets lose proportionally more muscle. The whole point of the protocol is the protein-sparing effect, which is why total-starvation regimens for obesity were abandoned (Blackburn and Bistrian, Harvard, 1970s; ProMoFasT RCT, Nutrients 2023).

  • Often saidThe 1970s deaths prove the diet itself is lethal

    ActuallyThe deaths are associated with poorly formulated commercial collagen and gelatin liquid-protein products used largely without supervision, not with properly formulated supervised PSMF. Frank et al. (Int J Obes 1981) found no properly managed patient died as a direct result, attributing fatalities to mismanagement and preexisting cardiac disease. The corrective lesson is supervision and protein quality, not abandonment.

  • Often saidIt is a casual at-home diet

    ActuallyPSMF is a very-low-calorie medical protocol with a documented history of harm when poorly formulated. Modern guidance treats very-low-calorie ketogenic approaches as something to carry out under a health professional's supervision with periodic lab monitoring (Muscogiuri et al., European VLCKD guideline, Obesity Facts 2021).

Who profits, and who pushes back

  • Arthur Frank (with Graham and Frank)

    Pushes backAuthors, Fatalities on the liquid-protein diet, International Journal of Obesity 1981

    In their analysis, no properly managed patient died as a direct result of the liquid protein diet, and most analyzable deaths involved inappropriate management or preexisting cardiac disease rather than the diet itself.

  • NIH National Task Force on the Prevention and Treatment of Obesity

    Pushes backExpert panel, very-low-calorie diet position (JAMA 1993)

    Very-low-calorie diets should be used only under the supervision of experienced personnel in a medical setting where the patient can be medically monitored, and only in limited circumstances.

  • Giovanna Muscogiuri and colleagues

    Pushes backAuthors, European VLCKD systematic review and meta-analysis, Obesity Facts 2021

    A very-low-calorie ketogenic diet can be considered a safe nutritional approach under a health professional's supervision, since the most common side effects are usually mild and easily managed, and it should be carried out with periodic monitoring.

  • Dr. George Blackburn

    Promotes itHarvard obesity medicine

    Pioneered the protein-sparing modified fast in the 1970s as a safer, muscle-preserving clinical weight-loss tool.

  • Bariatric & obesity clinicians

    Promotes itMedical weight management

    Use supervised PSMF in specific clinical contexts, with electrolyte and protein monitoring.

  • Low-carb program sellers

    Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.

    Promotes itCommercial diets

    Market PSMF-style "fat fast" and high-protein rapid-loss programs to consumers, sometimes without the medical safeguards the protocol requires.

Where the research comes from

Most of the published research on this comes from one place. 55% of it is from USA. Findings that no unrelated group has reproduced are weaker than the study count makes them look.

Share of published research by country of origin.
PlaceShare of published research
USA55%
Europe25%
Other20%

Research published from: USA, Global.

How we got here

Total starvation for obesity was studied in the mid-twentieth century but stripped lean tissue alongside fat. The protein-sparing modified fast emerged in 1970s United States clinical obesity medicine, credited to George Blackburn and Bruce Bistrian at Harvard, who kept dietary protein high specifically to defend muscle during rapid loss. Running alongside this careful clinical work was a commercial shortcut: Robert Linn's 1976 The Last Chance Diet and his Prolinn drink, a low-biological-value collagen and gelatin hydrolysate derived from animal hides and hooves, sold for largely unsupervised home use. Between 1977 and 1978, roughly 58 to 60 deaths, predominantly in women aged 25 to 44, were reported to the FDA and CDC among avid liquid-protein dieters, with autopsies and monitoring showing QT prolongation and ventricular arrhythmia. The FDA issued warnings from 1977 and tightened labeling by 1980. Properly formulated, supervised PSMF survived as a tool in modern medical weight management.

  1. 1970sBlackburn and Bistrian at Harvard develop the protein-sparing modified fast to preserve lean mass during rapid loss
  2. 1976Robert Linn publishes The Last Chance Diet and markets the Prolinn collagen and gelatin liquid-protein drink for largely unsupervised use
  3. 1977-1978Roughly 58 to 60 deaths, mostly women, reported to the FDA and CDC among liquid-protein dieters; FDA issues warnings
  4. 1978NEJM publishes a case report of sudden death on a liquid protein diet; cardiac investigation intensifies
  5. 1979Circulation and related reports document QT prolongation and ventricular arrhythmia in liquid-protein-diet deaths
  6. 1980FDA tightens labeling and supervision requirements for protein products and very-low-calorie diets
  7. 1981Frank et al. (Int J Obes) argue the deaths reflected mismanagement and preexisting cardiac disease rather than the diet itself
  8. 1985Palgi, Bistrian, Blackburn and colleagues report 668 supervised outpatients with mean loss of about 21 kg
  9. 2023ProMoFasT open-label RCT (Nutrients) compares tube versus oral PSMF in 44 adults over 150 days

At a glance

Core idea
High protein, near-zero carbs/fat
Goal
Preserve lean mass during rapid loss
Origin
1970s clinical obesity medicine
Caution
Best done under medical supervision

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Protein-Sparing Modified Fast. A short entry is not a safe entry.

  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources